Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-infectious Intermediate and Posterior Uveitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00908466
What this trial is testing

Sirolimus as Therapeutic Approach to Uveitis

Who this might be right for
UveitisIntermediate UveitisPosterior Uveitis+1 more
Johns Hopkins University 30
Large-scale testing (Phase 3)Study completedNCT00404612
What this trial is testing

LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis

Who this might be right for
Uveitis, PosteriorUveitis, IntermediatePanuveitis
Lux Biosciences, Inc. 218
Large-scale testing (Phase 3)Ended earlyNCT01032915
What this trial is testing

Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis

Who this might be right for
Non-infectious Uveitis
Novartis Pharmaceuticals 125
Testing effectiveness (Phase 2)Study completedNCT00685399
What this trial is testing

Safety and Efficacy of AIN457 in Noninfectious Uveitis

Who this might be right for
Non-infectious Uveitis
Novartis Pharmaceuticals 76
Large-scale testing (Phase 3)Study completedNCT02746991
What this trial is testing

Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis

Who this might be right for
Posterior UveitisIntermediate UveitisPanuveitis
EyePoint Pharmaceuticals, Inc. 153
Not applicableUnknownNCT04126850
What this trial is testing

Pilot Project: The Amplicon and Metatranscriptomic Study of Intra and Extra Intestinal Microbiome in Non-infectious Uveitis Disease

Who this might be right for
Autoimmune UveitisBehçet DiseaseVogt-Koyanagi-Harada Disease+5 more
Fakultas Kedokteran Universitas Indonesia 10
Large-scale testing (Phase 3)Study completedNCT00333814
What this trial is testing

The Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis

Who this might be right for
Intermediate UveitisPosterior Uveitis
Allergan 229
Early research (Phase 1)Study completedNCT00001526
What this trial is testing

ANTI-TAC THERAPY FOR UVEITIS

Who this might be right for
Uveitis
National Eye Institute (NEI) 15
Large-scale testing (Phase 3)Study completedNCT00404742
What this trial is testing

LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis

Who this might be right for
Uveitis, PosteriorUveitis, IntermediatePanuveitis
Lux Biosciences, Inc. 232
Testing effectiveness (Phase 2)Study completedNCT05523765
What this trial is testing

Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis

Who this might be right for
Non-infectious Intermediate UveitisNon-infectious Posterior UveitisNon-infectious Pan Uveitis
Priovant Therapeutics, Inc. 26
Large-scale testing (Phase 3)Study completedNCT01148225
What this trial is testing

The Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis

Who this might be right for
Uveitis
AbbVie 424
Testing effectiveness (Phase 2)Study completedNCT01526889
What this trial is testing

Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,

Who this might be right for
Non-infectious Intermediate UveitisNon-infectious Posterior UveitisNon-infectious Panuveitis
Novartis Pharmaceuticals 25
Post-approval studies (Phase 4)Study completedNCT05414201
What this trial is testing

Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or Pan-Uveitis

Who this might be right for
Non-infectious Intermediate Posterior- or Pan-uveitis
AbbVie 87
Testing effectiveness (Phase 2)WithdrawnNCT01280669
What this trial is testing

Intravitreal Sirolimus as Therapeutic Approach to Uveitis

Who this might be right for
UveitisIntermediate UveitisPosterior Uveitis+1 more
Stanford University
Not applicableStudy completedNCT03339102
What this trial is testing

Post-marketing Surveillance Study of Adalimumab (Humira®) for Non-infectious Intermediate, Posterior, or Panuveitis Patients

Who this might be right for
Non-infectious Intermediate, Posterior and Panuveitis
AbbVie 158
Large-scale testing (Phase 3)Ended earlyNCT01095250
What this trial is testing

Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis

Who this might be right for
Uveitis
Novartis Pharmaceuticals 30
Large-scale testing (Phase 3)Ended earlyNCT01684345
What this trial is testing

Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis

Who this might be right for
Uveitis
XOMA (US) LLC 200
Early research (Phase 1)Study completedNCT00280826
What this trial is testing

Efalizumab to Treat Uveitis

Who this might be right for
UveitisMacular Edema
National Eye Institute (NEI) 6
Testing effectiveness (Phase 2)UnknownNCT01717170
What this trial is testing

Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study

Who this might be right for
Intermediate UveitisPosterior UveitisPan-uveitis
University of Nebraska 36
Testing effectiveness (Phase 2)Study completedNCT04706741
What this trial is testing

A Trial of the Efficacy and Safety of Izokibep in the Treatment of Non-anterior Uveitis

Who this might be right for
Uveitis
ACELYRIN Inc. 7
Next Page